[Plasma exchange combined with double plasma absorption therapy improve the prognosis of acute-on-chronic liver failure]
- PMID: 30481880
- DOI: 10.3760/cma.j.issn.1007-3418.2018.10.003
[Plasma exchange combined with double plasma absorption therapy improve the prognosis of acute-on-chronic liver failure]
Abstract
Objective: To compare the efficacy and safety of plasma exchange (PE) combined with double plasma absorption and simple PE in the treatment of acute-on-chronic liver failure. Methods: We retrospectively analyzed 251 cases of acute-on-chronic liver failure treated with artificial liver treatment since January 2015. Changes in clinical manifestations, laboratory tests, and complications of the patients before and after different modes of treatment were compared and short-term efficacy was tracked. In accordance with different data, t-test, Pearson's chi-squared test and Fisher's exact test were used for statistical analysis. Results: The effectiveness of low-volume PE combined with double plasma molecular adsorption system (DPMAS) and equal amount of PE combined with DPMAS was significantly better than simple PE (83.7%, 84.05% and 82.15 vs 55.6%, P < 0.05) in early stage of liver failure. In late-stage of liver failure, there was no significant difference in the treatment efficiency of each group (P > 0.05). Bilirubin and bile acid levels were significantly decreased in combined treatment groups than that to simple PE group (P < 0.05). PTA and albumin improvement rate of DPMAS PE groups were significantly lower than that of simple PE group (P < 0.05). There was no statistical difference in adverse reactions between each group. Conclusion: PE combined with DPMAS improves the treatment efficiency of early hepatic failure and decrease dosage of plasma when compared with simple PE. A beforehand DPMAS treatment after PE treatment can improve the adverse effects of DPMAS on blood coagulation function and albumin levels.
目的: 比较血浆置换(PE)联合双重血浆吸附与单纯PE治疗慢加急性肝衰竭的疗效和安全性。 方法: 回顾性分析2015年1月以来收治的经人工肝治疗的慢加急性肝衰竭患者251例。比较不同模式治疗前后患者症状、体征、实验室检查以及并发症的变化情况,并追踪近期疗效。据资料不同用t检验、Pearson χ(2)检验或者Fisher确切概率法进行统计学分析。 结果: 早期肝衰竭,低置换PE联合双重血浆分子吸附系统(DPMAS)(83.7%)和等量PE联合DPMAS治疗有效率(84.0%和82.1%)明显优于单纯的足量PE(55.6%)(P < 0.05)。中晚期肝衰竭,各组治疗有效率差异无统计学意义(P > 0.05)。联合治疗组的胆红素下降率、胆汁酸下降率均明显优于PE组(P < 0.05)。低置换量PE联合DPMAS(LPE+DPMAS)组,先PE后DPMAS组的凝血酶原活动度改善率,白蛋白改善率均明显低于PE组(P < 0.05)。先DPMAS后PE组凝血酶原活动度改善率和白蛋白改善率与PE组差异无统计学意义。各组不良反应发生差异无统计学意义。 结论: 较单纯PE而言,PE联合DPMAS既能提高早期肝衰竭治疗有效率,还能减少血浆用量。先行DPMAS治疗后行PE治疗,能改善DPMAS对凝血功能和白蛋白水平的不良影响。.
Keywords: Double plasma molecular absorption system; Liver failure; Non-bioartificial liver support system; Plasma exchange.
Similar articles
-
Comparison of plasma exchange, double plasma molecular adsorption system, and their combination in treating acute-on-chronic liver failure.J Int Med Res. 2020 Jun;48(6):300060520932053. doi: 10.1177/0300060520932053. J Int Med Res. 2020. PMID: 32552092 Free PMC article.
-
Therapeutic effect of double plasma molecular adsorption system and sequential half-dose plasma exchange in patients with HBV-related acute-on-chronic liver failure.J Clin Apher. 2019 Aug;34(4):392-398. doi: 10.1002/jca.21690. Epub 2019 Feb 13. J Clin Apher. 2019. PMID: 30758886 Free PMC article.
-
[Analysis of curative effect and short-term survival rate of plasma exchange and double plasma molecular adsorption combined with half-volume plasma exchange in the treatment of liver failure].Zhonghua Gan Zang Bing Za Zhi. 2023 Jul 20;31(7):736-741. doi: 10.3760/cma.j.cn501113-20230228-00083. Zhonghua Gan Zang Bing Za Zhi. 2023. PMID: 37580257 Chinese.
-
The Clinical Efficacy of Double Plasma Molecular Absorption System Combined with Plasma Exchange in the Treatment of Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis.J Healthc Eng. 2022 Mar 25;2022:3139929. doi: 10.1155/2022/3139929. eCollection 2022. J Healthc Eng. 2022. PMID: 35368957 Free PMC article.
-
Non-bioartificial liver support system in the treatment of pediatric acute liver failure.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025 Feb 28;50(2):266-274. doi: 10.11817/j.issn.1672-7347.2025.240184. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025. PMID: 40523769 Review. Chinese, English.
Cited by
-
Analysis of Efficacy and Safety of Small-Volume-Plasma Artificial Liver Model in the Treatment of Acute-On-Chronic Liver Failure.Physiol Res. 2023 Dec 31;72(6):767-782. doi: 10.33549/physiolres.935158. Physiol Res. 2023. PMID: 38215063 Free PMC article.
-
Association between volume of processed plasma and total bilirubin reduction during plasma adsorption for severe liver disease.Eur J Med Res. 2025 Mar 15;30(1):175. doi: 10.1186/s40001-025-02419-4. Eur J Med Res. 2025. PMID: 40089798 Free PMC article.
-
[Application of double plasma molecular adsorption system in children with acute liver failure].Zhongguo Dang Dai Er Ke Za Zhi. 2021 Feb;23(2):180-185. doi: 10.7499/j.issn.1008-8830.2010145. Zhongguo Dang Dai Er Ke Za Zhi. 2021. PMID: 33627215 Free PMC article. Chinese.
-
Comparison of plasma exchange, double plasma molecular adsorption system, and their combination in treating acute-on-chronic liver failure.J Int Med Res. 2020 Jun;48(6):300060520932053. doi: 10.1177/0300060520932053. J Int Med Res. 2020. PMID: 32552092 Free PMC article.
-
Efficacy and safety of artificial liver support system treatment for immune checkpoint inhibitors related liver failure in patients with hepatocellular carcinoma: Protocol for a randomized controlled clinical trial.Heliyon. 2024 Oct 9;10(20):e39095. doi: 10.1016/j.heliyon.2024.e39095. eCollection 2024 Oct 30. Heliyon. 2024. PMID: 39640621 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources